Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation

Nature Immunology

Volumn 13, Issue 9, 2012, Pages 864-871

  Van Gisbergen, Klaas P J M ^a,b,d   Kragten, Natasja A M ^a,b   Hertoghs, Kirsten M L ^b   Wensveen, Felix M ^c   Jonjic, Stipan ^c   Hamann, Jörg ^b   Nolte, Martijn A ^a,b   Van Lier, Rene A W ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF RIJEKA   (Croatia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; GAMMA INTERFERON; GRANZYME B; HOBIT PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENE REPRESSION; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; STEADY STATE; THYMOCYTE; TRANSCRIPTION TERMINATION;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; FLOW CYTOMETRY; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NATURAL KILLER T-CELLS; PHYLOGENY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84865424065     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2393     Document Type: Article

References (41)

1. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007). (Pubitemid 46697911)
2. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182, 2091-2096 (1995).
3. Mendiratta, S.K. et al. CD1d1 mutant mice are defcient in natural T cells that promptly produce IL-4. Immunity 6, 469-477 (1997). (Pubitemid 27208202)
4. Benlagha, K., Wei, D.G., Veiga, J., Teyton, L. & Bendelac, A. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202, 485-492 (2005). (Pubitemid 41186947)
5. Benlagha, K., Kyin, T., Beavis, A., Teyton, L. & Bendelac, A. A thymic precursor to the NK T cell lineage. Science 296, 553-555 (2002). (Pubitemid 34408679)
6. Pellicci, D.G. et al. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1-CD4+ CD1d-dependent precursor stage. J. Exp. Med. 195, 835-844 (2002). (Pubitemid 34286755)
7. Egawa, T. et al. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22, 705-716 (2005). (Pubitemid 40814501)
8. Kovalovsky, D. et al. The BTB-zinc fnger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9, 1055-1064 (2008).
9. Savage, A.K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391-403 (2008).
10. Matsuda, J.L. et al. T-bet concomitantly controls migration, survival, and effector functions during the development of Vα14i NKT cells. Blood 107, 2797-2805 (2006).
11. Townsend, M.J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20, 477-494 (2004). (Pubitemid 38482125)
12. + T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 187, 967-972 (1998). (Pubitemid 28141670)
13. Kim, P.J. et al. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 177, 6650-6659 (2006). (Pubitemid 44715028)
14. Mycko, M.P. et al. Selective requirement for c-Myc at an early stage of Vα14i NKT cell development. J. Immunol. 182, 4641-4648 (2009).
15. Lazarevic, V. et al. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10, 306-313 (2009).
16. Walunas, T.L., Wang, B., Wang, C.R. & Leiden, J.M. Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J. Immunol. 164, 2857-2860 (2000). (Pubitemid 30148940)
17. Lacorazza, H.D. et al. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 17, 437-449 (2002). (Pubitemid 35223533)
18. Stanic, A.K. et al. NF-kappa B controls cell fate specifcation, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 172, 2265-2273 (2004). (Pubitemid 38182374)
19. Bikoff, E.K., Morgan, M.A. & Robertson, E.J. An expanding job description for Blimp-1/PRDM1. Curr. Opin. Genet. Dev. 19, 379-385 (2009).
20. Nutt, S.L., Fairfax, K.A. & Kallies, A. BLIMP1 guides the fate of effector B and T cells. Nat. Rev. Immunol. 7, 923-927 (2007). (Pubitemid 350166060)
21. + T cells and memory responses. Immunity 31, 283-295 (2009).
22. + T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31, 296-308 (2009).
23. + T cell exhaustion during chronic viral infection. Immunity 31, 309-320 (2009).
24. Kallies, A. et al. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. Blood 117, 1869-1879 (2011).
25. Smith, M.A. et al. PRDM1/Blimp-1 controls effector cytokine production in human NK cells. J. Immunol. 185, 6058-6067 (2010).
26. + T cell differentiation. J. Clin. Invest. 120, 4077-4090 (2010).
27. Kreslavsky, T. et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc. Natl. Acad. Sci. USA 106, 12453-12458 (2009).
28. Stenström, M., Skold, M., Andersson, A. & Cardell, S.L. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defned in BALB.NK mice. Immunology 114, 336-345 (2005). (Pubitemid 40314806)
29. + T cells. Nat. Immunol. 11, 709-716 (2010).
30. McNab, F.W. et al. Peripheral NK1.1 NKT cells are mature and functionally distinct from their thymic counterparts. J. Immunol. 179, 6630-6637 (2007).
31. Crowe, N.Y. et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 171, 4020-4027 (2003). (Pubitemid 37238677)
32. Wingender, G., Krebs, P., Beutler, B. & Kronenberg, M. Antigen-specifc cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency. J. Immunol. 185, 2721-2729 (2010).
33. Fehniger, T.A. et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798-811 (2007). (Pubitemid 46907665)
34. Bubić, I. et al. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78, 7536-7544 (2004). (Pubitemid 38915900)
35. Tyznik, A.J. et al. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181, 4452-4456 (2008).
36. Paget, C. et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27, 597-609 (2007). (Pubitemid 47628833)
37. + T cells in the lung airways during respiratory virus challenge. Immunity 33, 96-105 (2010).
38. Brigl, M., Bry, L., Kent, S.C, Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237 (2003). (Pubitemid 37540692)
39. Brigl, M. et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208, 1163-1177 (2011).
40. + natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect. 9, 364-374 (2007). (Pubitemid 46350859)
41. Cimmino, L. et al. Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. J. Immunol. 181, 2338-2347 (2008).